Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02742662 · ClinicalTrials.gov registry record · NA
Smart Technology for Weight Loss and Metabolic Health
A NA study, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT02742662: Completed NA study, sponsored by Temple University.
NCT02742662 is a NA study that has completed, run by Temple University. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02742662, a NA study, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The study will evaluate whether a technology-based lifestyle intervention program using primarily a smartphone platform is an acceptable and effective way for treating obesity. The goal of the program is to achieve weight loss and enhance the health of overweight or obese subjects by improving their diet and activity via smartphone applications as compared with conventional in-person weight management programs.
Interventions
- DEVICE Wearable technology, smartscale
- BEHAVIORAL Smartphone applications
- BEHAVIORAL Standard Weight Management Visits
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-11 |
| Phase | NA |
What the finished NCT02742662 record still lists
NCT02742662 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Wearable technology, smartscale is the first listed.
NCT02742662 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02742662 about?
NCT02742662 is a clinical study titled "Smart Technology for Weight Loss and Metabolic Health". The study will evaluate whether a technology-based lifestyle intervention program using primarily a smartphone platform is an acceptable and effective way for treating obesity. The goal of the program is to achieve weight loss and enhance the health of overweight or obese subjects by improving their...
What is the current status of trial NCT02742662?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2016-04. Estimated completion is 2017-11.
What interventions are being tested in trial NCT02742662?
The interventions under investigation include: Wearable technology, smartscale (DEVICE), Smartphone applications (BEHAVIORAL), Standard Weight Management Visits (BEHAVIORAL).
Who is sponsoring clinical trial NCT02742662?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02742662's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia